Home Latest Drug News News Blog Sun Pharmaceuticals Inc. Receives FDA Approval

Drug Manufacturer Sun Pharmaceuticals Inc., has received tentative approval from the Food and Drug Administration (FDA) to market a generic 5 mg and 10 mg version of donepezil hydrochloride tablets, which are used to treat Alzheimer's disease in the American market, under the brand name Aricept.

According to the National Cancer Institute, donepezil hydrochloride works by blocking the hydrolysis of the neurotransmitter acetylcholine and, consequently, increasing its activity. This agent may improve neurocognitive function in Alzheimer's disease, reduce sedation associated with opioid treatment of cancer pain, and improve neurocognitive function in patients who have received radiation therapy for primary brain tumors or brain metastases.

 
Have You Been Injured?
Free Claim Review
If you or a loved one have suffered a serious injury or side effect related to drug or supplement, please contact us for a free and confidential case review.
 

 

 

 

 

 

 

 

 



 

 

 

 

 

  
 
 
Polls
Do You Think The FDA Is Doing Enough To Protect Consumers?
 
Facebook MySpace Twitter Digg Delicious Stumbleupon Google Bookmarks RSS Feed